First Court Hearing for Biomet Hip Lawsuits Completed, Litigation Presses On
To the relief of plaintiffs who have filed claims over the controversial Biomet Magnum M2a hip implant, there don’t seem to be many stalemates preventing the multidistrict litigation (MDL) for Biomet hip lawsuits from moving forward at a swift pace.
According to court records, the status conference held Nov. 16 marked the next step in the proceedings led by U.S. District Judge Robert L. Miller Jr. by allowing attorneys involved in the litigation to make suggestions as to its management. One of those suggestions was for Judge Miller to consider appointing a plaintiffs’ steering committee, which is expected to be decided within the next few weeks. The federal MDL for Biomet hip lawsuits is based in the U.S. District Court for the Northern District of Indiana.
There are almost a hundred Biomet hip lawsuits pending in federal courts, and at least another 400 waiting to be filed by lawyers who attended the November hearing, according to reports. Court records indicate there will be around one thousand Biomet hip lawsuits filed in the federal MDL, which was officially created Oct. 2 by the U.S. Judicial Panel on Multidistrict Litigation. At the time, there were eight Biomet hip lawsuits filed in federal court, and 57 potential claims pending in state courts around the U.S.
Officials at Biomet Inc. may be already starting to feel the brunt of this litigation in their wallets. A Bloomberg Businessweek article published Oct. 11 revealed that the company’s earnings dropped this quarter, specifically in its sales from hip and knee implants. It was reported that Biomet’s revenue from joint reconstruction products fell 1 percent due to lower sales volumes in the department.
Plaintiffs who have filed Biomet hip lawsuits allege they suffered health complications stemming from metallosis—a condition that results when metallic components of the implant rub together and shred debris into the bloodstream. After being implanted with the device, patients may experience pain, swelling and even pseudotumors.